OXT and post-traumatic stress disorder: Pharmaceutical treatment with MDMA results in elevated oxytocin release, facilitating emotional processing that supports sociability.[110] In 2017, the FDA granted MDMA a breakthrough therapy focusing on PTSD in Lykos Therapeutics.[111] Since patients with PTSD feel numb and are less interested in others, MDMA was aimed at improving the sensation of deprivation.